Sale!

Poor Quality Pharmaceuticals in Global Public Health

Original price was: د.إ764.00.Current price is: د.إ660.00.

Colour Matt Finished

Description

Pages:
233
Language:
English
Format:
PDF
Size:
4 MB
ISBN-10:
9811520887
ISBN-13:
978-9811520884

(Trust (5)) 1st ed. 2020 Edition

by Satoru Kimura (Author), Yasuhide Nakamura (Author)

This book aims to clarify the global aspects of poor quality pharmaceuticals, generic products in particular, becoming complicated through the process of IMPACT (International Medical Products Anti-Counterfeiting Taskforce) organized by the initiative of the World Health Organization (WHO) in 2006. The findings from this book provide a long-term perspective to policymakers. This book discusses from the following points: industrial standardization, healthcare market accessibility, motivation on supply side, WHO medicines policy and intellectual property rights. Standardization regulates the quality and enabled the generic medicines spreading to developing/emerging countries through technology transfer. However, quality is a part of cost and reflected to price. When a healthcare service market is divided according to wealth gap, compliance to standardization for quality on supply side is divided accordingly. Thus, poor quality pharmaceuticals are prevalent worldwide. Generic pharmaceuticals are essential resources in public health. The WHO has been involved in the dispute around the intellectual property rights under its intention to promote the new drug development for neglected diseases. Global pandemic of AIDs is a critical factor to accelerate the confusion. This created feelings of distrust among developing/emerging countries against developed countries if the WHO was in favour of developed countries. In addition to that, an easy and optimistic start of IMPACT stirred up conflicts of interests in the international community. The problem of poor quality pharmaceuticals became more complicated through the conflicts on intellectual property rights; patented drugs to generic drugs. A key for quality generic products is the formation of a single healthcare service market where good motivation on supply side together with fair competitiveness with patented pharmaceuticals and equitable access to services (both for the rich and the poor) are ensured. Political commitment to investment and regulatory infrastructure for the market is crucial.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

27
    27
    Your Cart
    Renal Medicine and Clinical Pharmacy
    1 X د.إ15.00 = د.إ15.00
    Tumor Microenvironment
    1 X د.إ765.00 = د.إ765.00
    Fast Like a Girl
    1 X د.إ82.00 = د.إ82.00
    Clinical Tuberculosis 6th Edition
    1 X د.إ150.00 = د.إ150.00
    Alzheimers Disease Diagnosis and Treatment Guide
    1 X د.إ100.00 = د.إ100.00
    Case Studies in Infectious Disease
    1 X د.إ175.00 = د.إ175.00
    Intragastric Balloon for Weight Management
    1 X د.إ802.00 = د.إ802.00
    Internal Fixation of the Spine
    1 X د.إ990.00 = د.إ990.00
    Anesthesia A Comprehensive Review 6th Edition
    1 X د.إ150.00 = د.إ150.00
    100 cases in UK Paramedic Practice
    1 X د.إ170.00 = د.إ170.00
    Handbook of Diffusion MR Tractography
    1 X د.إ852.00 = د.إ852.00
    The Behavioural Biology of Chickens By Siddaiah
    1 X د.إ6,700.00 = د.إ6,700.00
    Anesthesia for Urologic Surgery
    1 X د.إ250.00 = د.إ250.00
    Translational Interventional Radiology
    1 X د.إ970.00 = د.إ970.00
    Breath Analysis
    1 X د.إ1,469.00 = د.إ1,469.00
    It Was Her New York True Stories & Snapshots
    1 X د.إ132.00 = د.إ132.00
    Routledge Handbook of Water and Health
    1 X د.إ700.00 = د.إ700.00

    Add to cart